Mark A Lemmon, PhD, FRSAlfred Gilman Professor and Chair of Pharmacology; Co-director, Cancer Biology InstituteResearch InterestsErbB ReceptorsAdenocarcinomaBiochemistryCell MembraneCrystallographyMAP Kinase Signaling SystemHydrogen Deuterium Exchange-Mass SpectrometrySignal TransductionSingle Molecule ImagingReceptor AggregationProtein Kinase InhibitorsProtein Structure, TertiaryProtein-Tyrosine KinasesView Full Profile